The European Platform for Neurodegenerative Diseases (EPND) integrates existing initiatives to build, grow, and deliver a scalable and self-sustainable platform for storage and analysis of high-quality clinical samples and data collections. It is a public-private partnership funded by the Innovative Medicines Initiative (IMI), aiming to become a future European infrastructure, facilitating access to biological samples and data to accelerate biomarker discovery and validation and eventually support the development of therapeutics for neurodegenerative diseases.

The EPND project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101034344. The JU receives support from the European Union’s Horizon2020 research and innovation programme and EFPIA.


Representatives of Alzheimer Europe involved in the project:

Alzheimer Europe Staff - Project Officer - Angela Bradshaw
Ange leads Alzheimer Europe's involvement in the project.
Alzheimer Europe Staff - Director for Projects - Dianne Gove
Dianne participates in the Public Involvement work of EPND.
Daphné participates in the Public Involvement work of EPND.